These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

659 related items for PubMed ID: 7747155

  • 41. Reduction of renal stone risk by potassium-magnesium citrate during 5 weeks of bed rest.
    Zerwekh JE, Odvina CV, Wuermser LA, Pak CY.
    J Urol; 2007 Jun; 177(6):2179-84. PubMed ID: 17509313
    [Abstract] [Full Text] [Related]

  • 42. Dose dependency of calcium absorption: a comparison of calcium carbonate and calcium citrate.
    Harvey JA, Zobitz MM, Pak CY.
    J Bone Miner Res; 1988 Jun; 3(3):253-8. PubMed ID: 3213620
    [Abstract] [Full Text] [Related]

  • 43. [Oxalate stone prophylaxis by alkalinizing therapy (author's transl)].
    Butz M.
    Urologe A; 1982 May; 21(3):142-6. PubMed ID: 7048691
    [Abstract] [Full Text] [Related]

  • 44. Pathophysiology of incomplete renal tubular acidosis in recurrent renal stone formers: evidence of disturbed calcium, bone and citrate metabolism.
    Osther PJ, Bollerslev J, Hansen AB, Engel K, Kildeberg P.
    Urol Res; 1993 May; 21(3):169-73. PubMed ID: 8342250
    [Abstract] [Full Text] [Related]

  • 45. Renal calcium conservation in recurrent stone-formers with idiopathic hypercalciuria.
    Goulding A, Hocken AG.
    N Z Med J; 1985 Feb 13; 98(772):50-2. PubMed ID: 2983270
    [Abstract] [Full Text] [Related]

  • 46. Reduced vertebral bone density in hypercalciuric nephrolithiasis.
    Pietschmann F, Breslau NA, Pak CY.
    J Bone Miner Res; 1992 Dec 13; 7(12):1383-8. PubMed ID: 1481724
    [Abstract] [Full Text] [Related]

  • 47. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov 13; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 48. Value of routine citrate analysis and calcium/citrate ratio in calcium urolithiasis.
    Höbarth K, Hofbauer J.
    Eur Urol; 1991 Nov 13; 19(2):165-8. PubMed ID: 2022221
    [Abstract] [Full Text] [Related]

  • 49. Studies on citrate metabolism in normal subjects and kidney stone patients.
    Minisola S, Rossi W, Pacitti MT, Scarnecchia L, Bigi F, Carnevale V, Mazzuoli G.
    Miner Electrolyte Metab; 1989 Nov 13; 15(5):303-8. PubMed ID: 2811789
    [Abstract] [Full Text] [Related]

  • 50. Differences in metabolic urinary abnormalities in stone forming and nonstone forming patients with primary hyperparathyroidism.
    Sorensen MD, Duh QY, Grogan RH, Tran TC, Stoller ML.
    Surgery; 2012 Mar 13; 151(3):477-83. PubMed ID: 21893327
    [Abstract] [Full Text] [Related]

  • 51. [Influence of urinary citrate levels on spontaneous calcium oxalate dihydrate crystalluria].
    Hassani MA, Hennequin C, Lacour B, Daudon M.
    Prog Urol; 2005 Sep 13; 15(4):650-5. PubMed ID: 16459680
    [Abstract] [Full Text] [Related]

  • 52. Increased serum calcitonin, reduced serum 1,25-(OH)2-vitamin D and normal parathormone concentrations in idiopathic hypercalciuria.
    Lama G, Stile V, Ragone G, Meninno V, Senatore SN, Russo A, Lepore A, Scopacasa F, Iafusco D, Carbone A.
    Child Nephrol Urol; 2005 Sep 13; 9(3):135-7. PubMed ID: 3252962
    [Abstract] [Full Text] [Related]

  • 53. Plasma phospholipid arachidonic acid content and calcium metabolism in idiopathic calcium nephrolithiasis.
    Baggio B, Budakovic A, Nassuato MA, Vezzoli G, Manzato E, Luisetto G, Zaninotto M.
    Kidney Int; 2000 Sep 13; 58(3):1278-84. PubMed ID: 10972691
    [Abstract] [Full Text] [Related]

  • 54. Magnesium metabolism in renal stone disease.
    Johansson G, Backman U, Danielson BG, Ljunghall S, Wikström B.
    Invest Urol; 1980 Sep 13; 18(2):93-6. PubMed ID: 7410037
    [Abstract] [Full Text] [Related]

  • 55. Effect of potential renal acid load of foods on urinary citrate excretion in calcium renal stone formers.
    Trinchieri A, Lizzano R, Marchesotti F, Zanetti G.
    Urol Res; 2006 Feb 13; 34(1):1-7. PubMed ID: 16425021
    [Abstract] [Full Text] [Related]

  • 56. [Citric acid excretion in stone-formers and healthy controls on normal and standard diet (author's transl)].
    Bach D, Hesse A, Vahlensieck W.
    Urologe A; 1980 Jul 13; 19(4):220-5. PubMed ID: 7414767
    [Abstract] [Full Text] [Related]

  • 57. Evidence that postprandial reduction of renal calcium reabsorption mediates hypercalciuria of patients with calcium nephrolithiasis.
    Worcester EM, Gillen DL, Evan AP, Parks JH, Wright K, Trumbore L, Nakagawa Y, Coe FL.
    Am J Physiol Renal Physiol; 2007 Jan 13; 292(1):F66-75. PubMed ID: 17210796
    [Abstract] [Full Text] [Related]

  • 58. The efficacy of dietary intervention on urinary risk factors for stone formation in recurrent calcium oxalate stone patients.
    Siener R, Schade N, Nicolay C, von Unruh GE, Hesse A.
    J Urol; 2005 May 13; 173(5):1601-5. PubMed ID: 15821507
    [Abstract] [Full Text] [Related]

  • 59. [Studies on an oral calcium loading test in upper urinary tract stone formers].
    Orito M, Ohkawa M, Takemae K, Sugata T, Shimamura M, Okasho A, Hirano S, Hisazumi H.
    Hinyokika Kiyo; 1984 Jun 13; 30(6):721-8. PubMed ID: 6485963
    [Abstract] [Full Text] [Related]

  • 60. Acute effects of an oral calcium load in pregnancy and lactation: findings on renal calcium conservation and biochemical indices of bone turnover.
    Kent GN, Price RI, Gutteridge DH, Allen JR, Blakeman SL, Bhagat CI, St John A, Barnes MP, Smith M, Evans DV.
    Miner Electrolyte Metab; 1991 Jun 13; 17(1):1-7. PubMed ID: 1663206
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 33.